Article
CSL breaks ground on $1.5B Illinois immunoglobulin plant expansion
Strong Bullish
100.0
−100 Bearish
0
+100 Bullish
The Kanakee project builds on the biopharma company’s efforts to increase its U.S. footprint, where it has already spent more than $3 billion, and will focus on producing plasma-derived therapies.
Actions
Pulse AI
Pulse analysis not available yet. Click "Get Pulse" above.
Generated by Pulse AI, Glideslope's proprietary engine for interpreting market sentiment and economic signals. For informational purposes only — not financial advice.
Article Info
Source
Construction Dive
Published
Mar 11, 2026 · 2:25 pm
Article ID
59uqdi3
Original URL
Open source
Sentiment Signal
Strong Bullish
100.0
−100Neutral+100
More Like This